Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2011 - 2025)
Nu-Med Plus (NUMD) posted Liabilities and Shareholders Equity of $7911.0 for Q4 2025, up 56.72% sequentially from $5048.0 in Q3 2025, and down 15.6% YoY from $9373.0 in Q4 2024.
Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends
Nu-Med Plus has reported Liabilities and Shareholders Equity for 15 years, with the latest figure at $7911.0 in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 15.6% year-over-year to $7911.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26295.0 (down 27.5% YoY) and the FY2025 annual result came in at $7911.0, down 15.6% from the prior year.
- Liabilities and Shareholders Equity rose to $7911.0 in Q4 2025 per NUMD's latest filing, from $5048.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $285013.0 in Q1 2021 and troughed at $3168.0 in Q3 2022.
- A 5-year average of $36600.4 and a median of $10207.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity sank 97.22% in 2022, then jumped 645.26% in 2023.
- Over 5 years, Liabilities and Shareholders Equity stood at $22163.0 in 2021, then soared by 258.91% to $79545.0 in 2022, then tumbled by 83.08% to $13456.0 in 2023, then tumbled by 30.34% to $9373.0 in 2024, then dropped by 15.6% to $7911.0 in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $7911.0, $5048.0, and $8163.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | 12,909.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,911.00 |
| Sep 30, 2025 | 5,048.00 |
| Jun 30, 2025 | 8,163.00 |
| Mar 31, 2025 | 5,173.00 |
| Dec 31, 2024 | 9,373.00 |
| Sep 30, 2024 | 6,841.00 |
| Jun 30, 2024 | 11,041.00 |
| Mar 31, 2024 | 9,016.00 |
| Dec 31, 2023 | 13,456.00 |
| Sep 30, 2023 | 13,748.00 |
| Jun 30, 2023 | 36,547.00 |
| Mar 31, 2023 | 59,069.00 |
| Dec 31, 2022 | 79,545.00 |
| Sep 30, 2022 | 3,168.00 |
| Jun 30, 2022 | 8,440.00 |
| Mar 31, 2022 | 7,926.00 |
| Dec 31, 2021 | 22,163.00 |
| Sep 30, 2021 | 51,236.00 |
| Jun 30, 2021 | 89,130.00 |
| Mar 31, 2021 | 285,013.00 |